ARTICLE | Company News
Adeza other research news
October 14, 1996 7:00 AM UTC
Adeza received a $100,000 Phase I STTR to develop an assay to measure beta-3 integrin expression in human endometrium. The test aims to identify women with defects in uterine receptivity; women with d...